<DOC>
	<DOCNO>NCT02154854</DOCNO>
	<brief_summary>The purpose study compare parallel-group effect 4 month 12 month post-transplantation 2 value target residual concentration Advagraf vascular parameter de novo renal transplant patient .</brief_summary>
	<brief_title>Prospective Study Measure Vascular Parameters ( Ancillary Study ADEQUATE )</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Age 18 et 70 year Patient accept give write informed consent Recipients first renal allograft ( deceased living , non HLA identical donor compatible ABO blood type ) Randomized ADEQUATE study Patients must J112 +/ 3 day stable renal function ( MDRD 4 ) absence DSA since transplantation . Negative T crossmatch cytotoxicity Tolerate daily dose MMF 1g Acute rejection first month Existence BK infection since M3 Proteinuria/reatininuria ratio &gt; 1g/g since M3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Renal</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Arterial stiffness</keyword>
	<keyword>Vascular fibrose plasma marker</keyword>
</DOC>